
Please try another search
By Manas Mishra and Amruta Khandekar
(Reuters) -Drugmaker AbbVie Inc (NYSE:ABBV) on Friday raised its 2021 profit forecast on expectations that a rapid uptick in demand for its Botox anti-wrinkle injection due to the easing of COVID-19 curbs would continue for the rest of the year.
Sales of the drug for cosmetic uses rose two-fold to $584 million in the second quarter, trouncing analysts' estimates of $483 million as vaccinations encouraged people to resume non-essential procedures after being holed up at home for months.
The company acquired the drug last year as part of its $63 billion purchase of Allergan (NYSE:AGN). Company executives said on an earnings call that sales of products gained through the deal were on track to outpace Allergan's historical performance.
Increased investment in Botox and other aesthetic products is helping boost demand, Chief Executive Officer Richard Gonzalez said.
"About two-thirds of the performance, I think, is fundamental demand and maybe one-third of it is pent-up demand," Gonzalez added.
The company forecast full-year adjusted earnings between $12.52 and $12.62 per share, compared with $12.37 to $12.57 per share previously. Analysts expected 2021 earnings per share of $12.61, according to Refinitiv IBES data.
AbbVie also reported a 4.8% rise in quarterly sales of its best-selling drug Humira to $5.07 billion, roughly in line with expectations.
But sales of the drug, which is facing rivals in Europe, fell 6% on a reported basis in international markets while rising 7.1% in the United States.
AbbVie said the recent approval of Biogen (NASDAQ:BIIB)'s Alzheimer's disease drug had increased interest in treatments that clear brain plaques, a likely contributor to the disease.
The company expects to start testing a drug for Alzheimer's that works on the same mechanism by the end of the year or early next year.
Its shares were 1.7% lower at $116.88 in early trading.
By Aditi Shah NEW DELHI (Reuters) - Germany's Volkswagen AG (OTC:VWAGY) is exploring a partnership to supply electric components to Indian automaker Mahindra and Mahindra, the...
(Reuters) -Canada Goose Holdings Inc forecast annual earnings and revenue above Wall Street expectations after reporting a surprise quarterly profit on Thursday, encouraged by...
By Geoffrey Smith Investing.com -- Kohl's Corp (NYSE:KSS) slashed its full-year forecasts for sales and profit growth on Thursday, warning of a "considerable" slowdown in business...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.